Biomarker discovery & R&D programmes
GenXMap combines experimental multi-omics, bioinformatics and AI modelling to turn a biological question into results.
Core capabilities
Want to find the markers that separate two groups, and confirm them before you build on them?
Biomarker Xplorer profiles a discovery cohort, uses AI models to narrow thousands of candidates to a testable few, and confirms them by targeted quantification on the full sample set.
Explore the programme →Want to support your product claims with molecular evidence?
Skin Biology Xplorer shows how your cells, explants or 3D models respond to a compound, which biological pathways are involved, and what that says about its mechanism of action.
Explore the programme →Want to know how a treatment, a diet or a product reshapes the microbiome?
Microbiome Xplorer shows which communities change, which functions they carry, and how the host responds, on gut, skin or any other matrix your study calls for.
Explore the programme →Our workflow
Scientific Scoping
Your biological question turned into a study design: what to measure, on how many samples, and what has to hold up at the end.
GenXMapLaboratory work
Extraction and QC, sequencing, targeted quantification, protein analysis and extracellular vesicles, on our own OMICS4 platforms.
OMICS4 · by GenXMapModelling & interpretation
Models that narrow a long list of significant results down to the candidates worth following.
GenXMapScientific report
Methods, parameters and results, documented so your team can build on them.
GenXMapOMICS4 can also be booked on its own, if the analysis stays with you.
Both run in parallel on the same programme, under one scientific project lead: the design shapes the bench work, and the bench work is analysed by the people who designed it.
See how GenXMap runs your projectIndustries
Tumour and immune compartments profiled from the same collection, tissue and blood.
Molecular characterization for cell engineering and gene therapy programs.
Skin biology, transcriptomics and microbiome, on protocols held fixed across a formulation series.
Host-pathogen interactions and microbial ecology, down to low-biomass material.
Target validation and mechanism of action, from compound to molecular readout.
Our ecosystem
GenXMap is a member of Eurobiomed and France Biotech, is joining the Paris-Saclay Cancer Cluster and the Marseille Immunology Biocluster, and is established within the IHU Méditerranée Infection. That anchoring gives access to complementary expertise, clinical networks and technological platforms that reach beyond a single laboratory.
Clusters and biopoles
Got a project in mind?
A dedicated scientific team runs your project from sample to report.
Write to us